Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Cecelia Health Launches Spanish-Language Diabetes Resource Portal


Cecelia Health Launches Spanish-Language Diabetes Resource Portal

Cecelia Health Launches Spanish-Language Diabetes Resource Portal

Daily management of a chronic condition presents numerous barriers and challenges, but language should not be one of them.

To support the increasing number of Spanish-speaking people living with diabetes, Cecelia Health is thrilled to announce the launch of a new online resource portal to provide diabetes education and support for Hispanics. This free portal, designed by certified clinicians at Cecelia Health, will provide live education sessions, blog posts, and other valuable resources in Spanish.

As an aggregated group, U.S. Hispanics have one of the highest rates of diabetes (22.1%, compared to 12.1% for non-Hispanic Whites). As a group, they have a 50% likelihood of developing type 2 diabetes – and at a much younger age – compared to 40% for the overall U.S. population, according to the Centers for Disease Control.

Since inception as an omnichannel digital health provider, Cecelia Health clinicians have had over 1 million interactions with individuals living with diabetes and provided one-on-one chronic condition coaching and clinical care services. The creation of this portal was led by the initiative of this clinical team, who discovered a gap for Spanish-speakers attempting to obtain the help they need with diabetes management.

“When we reach out to Spanish-speaking patients, often they have never spoken to a practitioner in Spanish before. They may have been given a Spanish pamphlet if they’re lucky, but many are not given resources for where to seek help for the many daily needs that arise when managing diabetes.” said Nicole Anziani, MS, RD, CDN, CDCES, a Clinical Manager at Cecelia Health. “By providing as many resources as we can in Spanish, we can help decrease this language gap and disparity, since many of the Hispanics and Latinos we work with prefer to speak in Spanish as their primary language.”

The expert clinician team at Cecelia Health consists of Certified Diabetes Care and Education Specialists, Registered Dietician Nutritionists, Registered Nurses, and other highly credentialed individuals with diverse cultural backgrounds. Our expert clinician team includes over 10% bilingual specialists who support telemedicine programs with as many as 50% of participants who prefer to communicate in Spanish.

Cecelia Health’s clinician-led telehealth model has a proven track record of reducing A1C values by an average of 1.5 points.

About Cecelia Health

Cecelia Health positively transforms the lives of people living with diabetes and other chronic diseases. Our technology-enabled personalized coaching solution optimizes patient health outcomes at high ROI for our customers and healthcare partners via a tailored mix of expert clinician and digital health interactions. We work with partners to coach their members/patients and provide unique data-driven insights to health plans and ACOs seeking to improve quality measures, and pharmaceutical and medical device companies seeking to improve adherence. We actively support, partner and engage with various influential organizations within the diabetes community, including JDRF, Beyond Type 1, American Diabetes Association, the Diabetes Research Institute, the Association of Diabetes Care & Education Specialists, and The Jaeb Center for Health Research.

We deploy the optimized mix of personal and digital outreach as part of a holistic omnichannel approach to deliver the right touch at the right time. Our empathetic approach and intuitive engagement based on participant preference is powered by our proprietary, best-in-class digital platform to deliver tailored support to those who need it most.

http://www.ceceliahealth.com

Share article on social media or email:

Pricing, Interchangeability and Policy, Upcoming Webinar Hosted by Xtalks


Whilst the majority of EU countries have succeeded in achieving widespread acceptance by payers, providers and patients of biosimilars, these positive efforts have also revealed new challenges and risks.

Biological medicines represent a major advance in the treatment of serious pathological conditions such as cancer, neurodegenerative and autoimmune diseases. And biosimilars, as their cost-effective alternatives, improve patient access to modern therapy.

The European Medicines Agency (EMA) has been a pioneer in issuing scientific guidelines related to the regulatory requirements for the approval of biosimilars, with European National Authorities following similar efforts to enable access to these medicines.

After biosimilarity is demonstrated and products are authorized, manufacturers still struggle to access markets and ensure patients have access to them. And there are many reasons why, especially around pricing and policy at many different levels, that this is such a complex and interesting process.

Whilst the majority of EU countries have succeeded in achieving widespread acceptance by payers, providers and patients of biosimilars, these positive efforts have also revealed new challenges and risks.

The experience with biosimilars acquired to date has helped to strengthen trust in them. They are becoming more widely used by clinicians, and there is evidence that they can be used safely and effectively in their approved indications. In the near future, there is expected to be an avalanche of new biosimilars coming onto the market as the patents of innovator products expire.

It is therefore essential to discuss the regulatory challenges and share current experiences around biosimilars in readiness, which the panelists will do in this webinar, in order to spread both awareness and knowledge about them amongst all stakeholders.

Join Gabriela Marton, Regulatory Affairs Director, Quality Director, Arriello in a live webinar on Tuesday, November 24, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Biosimilars in Europe: Pricing, Interchangeability and Policy.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Vaccine Market Tops 37 Billion, Says Kalorama Information Report


Kalorama Information logo

There was a small decline in vaccine sales in 2020 due to COVID-19, but over the past five years, there’s been growth.

In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information’s report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025, specifically, the following findings were made:


  • Growth at high double-digit rates.
  • Sales of adult vaccines are expected to increase revenues at a faster pace than pediatric vaccines.
  • The United States comprises the single largest market for vaccines.
  • Despite a small decline between 2019 and 2020 due to COVID-19 and lockdowns, the vaccine market has grown seven billion dollars in the last five years.

“There was a small decline in vaccine sales in 2020 due to COVID-19, but over the past five years, there’s been growth,” said Bruce Carlson, Publisher of Kalorama Information.

More details are available in Kalorama’s report, including regional breakouts, disease-based market breakouts and forecasts, trends and other information. COVID-19 vaccines are not part of this market number, though Kalorama does forecast these in its report.

A mainstay of preventative medicine for over 70 years, a vaccine is a biological preparation used to trigger an immune response to a selected disease. The term derives from Edward Jenner’s use of cowpox (“vacca” means cow in Latin), which, when administered to humans, protected them against smallpox. Vaccines can be either prophylactic or therapeutic. Because of the large number of deadly diseases that have been virtually eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements during the 20th century. As a result of widespread public vaccination, vaccine-preventable diseases and their resulting deaths are now rare in the developed nations and declining worldwide. Immunizations have eradicated smallpox; eliminated poliomyelitis in the Americas; and controlled measles, rubella, tetanus, diphtheria, Haemophilus influenzae type b, and other infectious diseases.

Kalorama says the European market is presently the second largest global vaccine market, with nearly twenty percent of the market.

In 2020, the global market for human preventive vaccines experienced mixed performance in 2020 due to the impact of COVID-19. Sales overall declined from $38.4 billion in 2019 to $37.4 billion in 2020. Despite the overall decreased market performance, in 2020, the report said some segments reported increases, including shingles and influenza.

Kalorama’s report can be found at: https://kaloramainformation.com/product/vaccines-2020-world-market-analysis-players-trends/

About Kalorama Information:

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email:

NeuroFlow Integrates with Epic, Now Available in App Orchard Marketplace


NeuroFlow, the leader in technology-enabled behavioral health integration, is now available to healthcare providers through Epic’s App Orchard marketplace.

The launch is an encouraging development for health systems seeking to practice any of a range of collaborative care models, a clinical approach integrating both the physical and mental health of patients. Hospitals and health systems using Epic can deploy NeuroFlow to streamline clinical workflows and scale existing initiatives for measuring and treating patients’ mental health symptoms.

“We pride ourselves on creating a best-in-class user experience and a tool that augments the workflow of the modern clinician with actionable, insightful data,” said NeuroFlow Vice President of Product Management Julia Kastner. “By building an integration with Epic, the industry’s ‘gold standard’ EMR, we’ve made it easier for health systems to access and leverage behavioral health treatment in their care.”

The NeuroFlow integration with Epic will help organizations accelerate their efforts toward integrated care by facilitating reimbursement for collaborative care codes and optimizing value-based contracts.

The listing in Epic’s App Orchard is an important milestone for NeuroFlow, recently named the second-fastest growing company in Philadelphia, as it continues to enhance its technology and services to keep up with increasing demand for behavioral health tools amid the COVID-19 pandemic. NeuroFlow currently partners with hundreds of healthcare, insurance, and government organizations across the country, supporting over 250,000 users under contract.

Visit the NeuroFlow listing on the Epic App Orchard to learn more.

About NeuroFlow

NeuroFlow is a digital health company combining workflow automation, consumer engagement solutions, and applied AI to promote behavioral health integration in all care settings. NeuroFlow’s suite of HIPAA-compliant, cloud-based tools simplify remote patient monitoring, enable risk stratification, and facilitate collaborative care. With NeuroFlow, health care organizations can finally bridge the gap between mental and physical health in order to improve outcomes and reduce the cost of care. http://www.neuroflow.com.

Note: Epic and App Orchard are trademarks of Epic Systems Corporation.

Share article on social media or email:

American and Frenchman Turning Pro with Team Novo Nordisk


Logan Phippen was diagnosed with type 1 diabetes in 2016 over the weekend of his 24th birthday.

“Moving up to the pro ranks always means a new level of responsibility both as an athlete and as an ambassador to the diabetes community. I love getting to see Logan and Lucas’s dreams come true,” said Team Novo Nordisk CEO and co-founder Phil Southerland.

Team Novo Nordisk, the world’s first all-diabetes professional cycling team, brings up two of its best development riders, American Logan Phippen and Frenchman Lucas Dauge, onto the men’s pro squad for the 2021 season. Phippen serves as the USA-registered team’s first American on the men’s professional roster since 2018.

“Moving up to the pro ranks always means a new level of responsibility both as an athlete and as an ambassador to the diabetes community. I love getting to see Logan and Lucas’s dreams come true,” said Team Novo Nordisk CEO and co-founder Phil Southerland. “Through our extensive development pipeline, many of our athletes have a shared journey up to the pro ranks. When a devo rider advances to the pro team, it is a reunion with their past teammates. They help one another with the adjustments while serving as a reminder of the hard work and dedication it takes to reach the pro team.”

To become a member of Team Novo Nordisk, all athletes must have type 1 diabetes. Since its launch in December 2012, the organization has focused heavily on identifying and developing endurance athletes worldwide with diabetes. Dauge and Phippen are two in a long line of riders advancing through the team’s development pipeline. The team’s multi-tiered structure dedicates time and resources to allow riders to develop and help ensure a successful transition into the professional ranks.

Phippen was diagnosed with type 1 diabetes in 2016 over the weekend of his 24th birthday. The diagnosis never disheartened the Portland-native as he knew it was a condition that he could manage. With the help from his medical team, he was back on the bike within a week following his diagnosis. Because he had already seen Team Novo Nordisk in the peloton, he immediately reached out to the team to see if they had a spot for him on their elite team. Instead, Team Novo Nordisk offered him a chance to race for the development squad, and Phippen instantly jumped at the chance.

“My appreciation for this opportunity is immense and I am overflowing with gratitude to the team’s management for believing in me. I recognize this is a large step forward and I am motivated to continue distilling and refining my development process as I move into this new chapter,” said Phippen. “Pulling on the pro men’s jersey is quite special. Since I was a young child, racing at the pro level was my dream. My life has taken many courses and I’m so proud to pull on the Team Novo Nordisk Changing Diabetes jersey as we head into the 100th year anniversary since the discovery of insulin, meaning life for those of us living with diabetes.”

Dauge is set to become the third Frenchman amongst the Team Novo Nordisk ranks joining Mehdi Benhamouda and Charles Planet. The Hautes-Alpes-native was diagnosed with type 1 diabetes when he was 18 years old. He was a promising skier in his youth but fell in love with cycling after learning about Team Novo Nordisk. In 2017, he applied for Talent ID camp and began his journey through the team’s development pipeline.

“It’s a dream come true becoming a professional cyclist. I worked hard during the suspension of racing due to Covid-19 and managed to progress this season even without much racing,” explained Dauge. “When I joined the development team three years ago, I didn’t overthink about becoming a pro, but year after year, I saw with hard work that it could be possible, and it eventually became a goal that I believed in.”

The fight and desire Dauge has shown over the past years was a key factor for management when deciding to take him to the next step.

“It is with great pleasure to welcome Lucas to the professional team. He is a true fighter and worked extremely hard for this advancement,” said General Manager Vassili Davidenko. “Lucas’s story is very inspiring as a former skier who fell in love with cycling. He learned about the Team Novo Nordisk program via social media, attended Talent ID camp, and has become very dedicated to the sport. Within three seasons on our development team, he made significant progress, shown good results, and deserves his spot on the professional team for the 2021 season.”

Team Novo Nordisk ended its 2020 racing season at Paris-Tours. The team recently came together in Rhodes, Greece for a 2021 training camp before heading into the off-season.

About Team Novo Nordisk

Team Novo Nordisk is a global all-diabetes sports team of cyclists spearheaded by the world’s first all-diabetes professional cycling team. In 2012, Phil Southerland, co-founder and CEO of the team, and global healthcare company Novo Nordisk, came together to create Team Novo Nordisk, based on a shared vision to inspire, educate and empower people around the world affected by diabetes. For more information, go to http://www.teamnovonordisk.com.

# # #

Media Contact:

Fitzalan Crowe for Team Novo Nordisk

Fitzalan.crowe@teamnovonordisk.com

+1-703-596-2020

Share article on social media or email:

Navy SEAL Foundation Contributes $50,000 to Support Major PTSD Study


“I hope their powerful example encourages other organizations to support research into innovative and breakthrough therapies for ensuring the mental health of our veterans. Those who fight at the tip of the spear deserve cutting-edge treatments.” -Tim Ferriss

The Navy SEAL Foundation (NSF) recently pledged one of the organization’s largest single grants in its 20-year history to support a major Post Traumatic Stress Disorder (PTSD) study. The Foundation committed $50,000 to the project that could someday help injured military personnel, including Naval Special Warfare (NSW) veterans, through the use of the first-ever, psychedelic-assisted psychotherapy to earn Breakthrough Therapy designation from the FDA.

In partnership with noted author, podcaster and entrepreneur Tim Ferriss, NSF made the donation through the Multidisciplinary Association for Psychedelic Studies (MAPS). The Foundation joins more than 2,500 individual, corporate and benevolent foundation donors that contributed $30 million in under a year toward the MAPS’ psychedelic research fundraising campaign. Ferriss was one of the early challenge organizers who has personally contributed to the project through a generous $1 million gift.

“The Navy SEAL Foundation leads from the front,” said Ferriss. “It should come as no surprise that a foundation that exists to support Navy SEALs, some of the most high-performing individuals on the planet, would become the first military-serving nonprofit to step up and fund critical research into MDMA-assisted psychotherapy for PTSD. I hope their powerful example encourages other organizations to support research into innovative and breakthrough therapies for ensuring the mental health of our veterans. Those who fight at the tip of the spear deserve cutting-edge treatments.”

For years, NSF has worked to advance service-related issues such as PTSD, brain health, and Traumatic Brain Injury (TBI), along with holistic support for NSW veterans as they move from active-duty into civilian life. Their annual Whole Warrior Impact Forum has been instrumental in destigmatizing mental health issues while also advancing the conversation around veteran suicide prevention. MAPS is the first such study NSF has funded.

“This pioneering work has shown great promise and has now made its way into the mainstream. It is close to achieving a major goal by attaining FDA approval for MDMA-assisted psychotherapy as a treatment for PTSD,” said Navy SEAL Foundation CEO, Robin King. “We’re leaning in to help NSW and other veterans overcome the debilitating effects of PTSD,” King said. “The NSF Board took on this lead role and hopes to inspire other NSW supporting organizations to raise funds for this promising research also.”

When asked what NSF’s participation meant for the study, Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) responded, “We are delighted that the Navy SEAL Foundation has listened to those Navy SEALs who have found relief from PTSD through legal psychedelic-assisted psychotherapy outside the US and to those SEALs who are living with PTSD and haven’t found relief from the limited treatments available to them. By supporting the advancement of research into MDMA-assisted psychotherapy for PTSD, the Foundation is responding to an urgent need for their constituents: a PTSD treatment that may prove to be more effective than any other currently available option. This grant from the Foundation will facilitate the final drug approval Phase 3 study through the FDA — a gift to Navy SEALs and all who live with PTSD.”

Next year our nation will mark the 20th anniversary of 9/11 and the starting point of the most prolonged period of armed conflict our country has ever known. Young men who joined the Navy and became SEALs right after the attacks have endured two decades of harsh training and combat, and now many of them are beginning to retire from their service. These warriors have served bravely, they have lost teammates, and they have endured injuries and hardships that most of us cannot imagine. Without proper treatment, our veterans will continue to battle the adverse effects of their service-related experiences well into the future–and so will their families and caregivers.

It’s important to remember that positive outcomes from successful PTSD treatment extend to the patient’s family and caregivers, making the choice to invest in studies such as MAPS an easy one for the Navy SEAL Foundation.

About MAPS.

MAPS has a decades-long history of FDA-regulated research and education around the beneficial potential of psychedelic medicine. MAPS Public Benefit Corporation (MAPS PBC), a wholly owned subsidiary of MAPS, has been conducting MAPS-sponsored clinical trials of MDMA-assisted psychotherapy since 2014.

About the Navy SEAL Foundation:

The mission of the Navy SEAL Foundation (NSF) is to provide immediate and ongoing support and assistance to the Naval Special Warfare (NSW) community and its families, the families of NSW fallen, and SEAL and SWCC veterans.

U.S. Navy SEALs have been in sustained combat for nearly two decades, performing hazardous work in unforgiving environments at an unrelenting pace. NSW operators are currently deployed in over 30+ countries across the globe and can spend up to 270 days each year in harm’s way.

The Navy SEAL Foundation stands behind these warriors and their families by providing a comprehensive set of programs specifically designed to improve health and welfare, build and enhance resiliency, empower and educate families and provide critical support during times of illness, injury or loss.

Like the community it serves, the Navy SEAL Foundation is a high performing organization committed to excellence. NSF has been awarded the coveted 4-Star rating from Charity Navigator since 2011 and has earned a perfect score of “100” each year since 2016 for financial health, accountability, and transparency, placing NSF in the top 1% of rated charities. Ninety-four cents of every dollar donated goes directly to programs or is retained for future mission use.

The Navy SEAL Foundation is a 501c3 national non-profit charitable organization. TAX-ID 31-1728910. NSF is a non-federal entity, and it is not a part of the Department of Defense or any of its components, and it has no governmental status. To learn more, visit https://www.navySEALfoundation.org.

Share article on social media or email:

Top Fertility Specialist To Open New Clinic in Charlotte, North Carolina


Dr. Matrika Johnson, a top-rated board-certified Reproductive Endocrinologist and Infertility Specialist, will be opening a new boutique fertility clinic called Reproductive Specialists of the Carolinas this November. Located in Midtown Charlotte, NC, the new practice will include a state-of-the-art laboratory and will provide high-touch, comprehensive fertility care to patients throughout the Carolinas.

The fertility clinic is the first part of a larger grand opening – in 2021, Reproductive Specialists of the Carolinas will move into a new 11,000 square foot location. The new facility will enhance Reproductive Specialists of the Carolinas’ treatment offerings, which include standard options such as intrauterine insemination (IUI) and in vitro fertilization (IVF), as well as fertility assessments, oncofertility, egg freezing, embryo freezing, gestational surrogacy, and more.

Before becoming the founder and Medical Director of Reproductive Specialists of the Carolinas, Dr. Johnson spent the past five years in practice for the Charlotte market, where she made a name for herself in the Carolina fertility care community. Most recently in 2020, she was voted as one of Charlotte Magazine’s “Top Doctors” for the specialty of Reproductive Endocrinology and Infertility (REI). She is also the only female African American REI specialist in the entire state of North Carolina.

One of the main driving forces behind Dr. Johnson’s decision to open up a boutique fertility clinic in North Carolina has been her own personal experience. “As an infertility patient myself, I’m in a unique position to understand the experience from the patient perspective. This allows our team to improve upon the more traditional model and create a truly patient centered experience,” she says.

Personalized care will be the cornerstone of Reproductive Specialists of the Carolinas practice. “My patients aren’t just a number. I don’t want them to feel like it’s one size fits all,” says Dr. Johnson. “I want everyone to feel like their care is personalized. It’s really important to me that this practice focuses on each individual patient.”

Dr. Johnson also has a demonstrated history of inclusivity and has provided fertility care for a diverse range of patients from all backgrounds and situations, including LGBTQ+ families, single individuals, and others. “I believe that everyone deserves the chance to have a family,” she says.

Reproductive Specialists of the Carolinas will open and start seeing patients the week of November 24, 2020. The clinic will be located at 1918 Randolph Rd, Ste 210, Charlotte, NC 28207-1109. To learn more, please email info@fertilitycarolinas.com or call to schedule an appointment to see Dr. Johnson at (704) 247-2209.

Share article on social media or email:

Portable Root Board Gives New Meaning To “Yoga Anywhere”


The Root Board being used by yoga practitioner

The Root Board Portable Bamboo Platform is Ideal for Enhancing Yoga at Home on Carpet

Angeliki Papadakis, owner of Kefi Yoga in Torrance, California states, “The Root Board allows studios to professionally and safely move their classes outdoors,” she says. “Because of the Root Board, savvy yoga studios will be able to take their practice outside and provide what their clients need”

When the COVID-19 pandemic forced tens of millions of yogis out of their studios last spring, husband-and-wife team Brian and Kathy McCarthy saw an opportunity to help make the transition to practicing at home more fulfilling.

Knowing firsthand how carpeted floors inhibit the physical, emotional and spiritual relief of practicing on studio hardwood floors, the couple founded Root Self Care, LLC and created The Root Board, a portable hard surface that replicates the hardwood floors found in now-shuttered yoga studios.

Made of sustainable Moso bamboo, the Root Board is essential equipment to elevate yogis’ out-of-studio practices at home on carpet, or outdoors on grass, sand or dirt. The stable, beautiful and portable Root Board allows yogis to maintain their optimal practice anywhere there is a relatively flat surface.

“The benefits of a yoga practice are based on one’s ability to still the mind, focus, breathe and land a peak pose,” said Kathy McCarthy, co-founder of Root Self Care, LLC. “We call it the Root Board because, as all yogis know, you have to ‘root to rise.’”

Yoga instructors and studio owners, too, have had to rush to find new, creative solutions to the restrictions and social distancing requirements imposed on their businesses. Studio owner Angeliki Papadakis, owner of Kefi Yoga in Torrance, California believes the Root Board will change the yoga industry. “The Root Board allows studios to professionally and safely move their classes outdoors,” she says. “Because of the Root Board, savvy yoga studios will be able to take their practice outside and provide what their clients need.”

According to the 2016 Yoga in America Study conducted by Yoga Journal and Yoga Alliance there were more than 36 million yoga practitioners in the United States, nearly two-thirds of whom practiced at home. With the pandemic spiking and little chance of returning to the studio for the foreseeable future, most yogis have moved their practices to their homes, where carpeted floors create a significant challenge to safely and comfortably landing poses without damaging their bodies.

Root Boards are available to pre-order and will ship in late-November. Instructors and influencers can also apply to participate in the Root Board referral program.

About Root Self Care, LLC

Founded in 2020 by husband-and-wife team, Brian and Kathy McCarthy, Root Self Care, LLC’s mission is to improve the lives of millions through empowering people to develop and maximize self-care routines. Root Self Care, LLC is the maker of the Root Board, a portable bamboo platform that enhances yoga practices outside the studio. For more information visit http://therootboard.com.

Share article on social media or email:

ChenMed Holds Second Annual Serving & Giving Week


ChenMed logo

We look forward to making a difference by doing valuable volunteer work for some outstanding community service organizations.

ChenMed, a leading provider of primary care focused on Medicare-eligible seniors, holds its second annual Serving and Giving Week, giving its 3,000 team members four hours of paid time off to volunteer in their communities. Between 1 and 5 p.m. one day this week, ChenMed team members will donate 12,000 paid volunteer hours valued at more than half a million dollars to collect food, help residents with laundry, make care packages and spruce up communities, among other activities.

“As a privately-held company that’s led by physicians, we care deeply about the communities where we are helping seniors thrive,” said Christopher Chen, M.D., CEO of ChenMed. “For this initiative, every one of our team members is focused on building relationships and giving back. We look forward to making a difference by doing valuable volunteer work for some outstanding community service organizations.”

For example, ChenMed senior medical centers are partnering with the “Lighter Loads” initiative in conjunction with LaundryCares Foundation to offer free laundry services to residents in underserved communities using nearby laundromats. ChenMed volunteers will be assisting with guests’ laundry needs. Some centers are setting up book donation areas where team members can bring books that will go to families in the communities they serve, promoting childhood literacy. In order to maintain a safe environment during Covid-19, families will be able to read the books to their children in their cars while they wait for their laundry to be done.

The LighterLoads events are taking place in Cleveland, Miami, New Orleans, Orlando, Palm Beach, Philadelphia, Richmond and Tidewater, Va. Nov. 11 between 1 and 5 p.m., weather permitting.

“We’re excited to offer free laundry services to help others fulfill the basic need of having clean clothes,” said Dan Naumann, executive vice president, LaundryCares Foundation. “It’s an honor to partner with ChenMed to further this initiative while also bringing childhood literacy resources to families in underserved communities.”

In Miami, a partnership with Feeding South Florida will host a drive-by collection of non-perishable items at ChenMed company headquarters in Miami Gardens, Fla. The donations will help create 60,000 healthy meals for families in need.

“We are grateful for ChenMed’s support during this time of increased need. This holiday season will be particularly hard for families. Donations help put food on the table for over 1 million people struggling to make ends meet,” says Feeding South Florida’s Executive Vice President, Sari Vatske.

Additional Serving and Giving Week volunteer activities are taking place in Atlanta, Cincinnati, Columbus, Jacksonville, Louisville, Memphis and St. Louis. Last year ChenMed team members volunteered with more than 40 community partners, including Habitat for Humanity, YMCA, Feeding South Florida, 4Kids, Miami Rescue Mission and Hope South Florida, amongst others. ChenMed doctors and care teams do community service work year-round.

During the coronavirus pandemic, through a series of 130 telephone town hall events sponsored as a community service, more than 100 Chen, Dedicated and JenCare Senior Medical Center doctors have educated more than 500,000 at-risk seniors about coronavirus risks; and proven ways to prevent infections and hospitalizations. These hour-long educational forums started in April, and in October started spotlighting a peer-reviewed journal paper showing how 400 seniors benefitting from high-touch primary care focused on prevention had 40% lower mortality from coronavirus.

About ChenMed

For seniors most in need of care, high-quality health care often is beyond reach. ChenMed brings concierge-style medicine — and better health outcomes — to the neediest populations. ChenMed is a privately owned medical, management and technology company that currently operates more than 75 primary care medical practices for diverse populations of seniors in 10 states. A provider of choice for some 20 Medicare Advantage health insurance plans, ChenMed is one of Fortune Magazine’s 2020 “Change the World” companies “taking on society’s unsolved problems – and boosting their business as a result.” ChenMed brands include Chen Senior Medical Center, Dedicated Senior Medical Center, and JenCare Senior Medical Center.

Share article on social media or email:

CBDProducts.com Releases New Pain Relief CBD Cream That Offers Up To 90% Absorption


CBD Cream with NanoZorb by CBD Products

For those feeling the effects of a tough workout, reeling after a long day at work, or just simply suffering from daily aches and pains, Cannabinoid Balance Pain Relief Cream+ could be the ideal solution.

Made with NanoZorb™ Technology in an FDA registered facility, this CBD cream from Cannabinoid Balance offers fast-acting, soothing relief. In fact, this nanotechnology will start to deliver all the goodness of Cannabinoid Balance Pain Relief Cream+ within just 2 minutes of application thanks to NanoZorb™ boosting absorption into the bloodstream to 90% vs 18% with other non-nano products.*

Like all Cannabinoid Balance products, Cannabinoid Balance Pain Relief Cream+ is:

  • Crafted from registered organic USA hemp
  • Non-THC / Non-GMO and CO2 Extracted
  • Free from Winterization, Decarboxylation, and pesticides
  • Formulated using proprietary NanoZorb™ Technology

Cannabinoid Balance products are all-natural and free of synthetics, sugar, binders, fillers, wax, shellac, talcum, and animal gelatin. It contains no yeast, wheat, corn, soy, gluten, salt, dairy, artificial flavors, sweeteners, colors, or preservatives.

*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.

NOTES TO THE EDITOR

CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.

CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb™ Technology designed to make Cannabinoid Balance products more effective and efficient.

It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.

For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.

Share article on social media or email: